Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area apoptosis bcl 2 family'

Search results for: 'research area apoptosis bcl 2 family'

Items 11-20 of 65

Page
per page
  1. GW441756
    B2297 GW441756
     1 Citation
    Target: Trk Receptors
    Summary: TrkA inhibitor,potent and selective
      insoluble in H2O; insoluble in EtOH; ≥13.75 mg/mL
  2. Lapatinib
    A8218 Lapatinib
     2 Citation
    Target: ErbB
    Summary: EGFR/HER2 inhibitor,potent,selective and reversible
      ≥29.05 mg/mL
  3. GSK1838705A
    A8440 GSK1838705A
    Target: Insulin and Insulin-like Receptors|ALK
    Summary: IGF-IR/IR/ALK inhibitor, ATP-competitive
      ≥26.65 mg/mL
  4. BMS-754807
    A1185 BMS-754807
    Target: Insulin and Insulin-like Receptors
    Summary: IGF-1R/InsR inhibitor,potent and selective
      ≥23.05 mg/mL
  5. ZM323881
    A3954 ZM323881
    Target: VEGFR
    Summary: VEGFR-2/KDR inhibitor,potent and selective
      Soluble in DMSO
  6. Gefitinib (ZD1839)
    A8219 Gefitinib (ZD1839)
     3 Citation
    Target: EGFR
    Summary: Selective EGFR inhibitor
      ≥22.34 mg/mL
  7. SU11274
    A2678 SU11274
     2 Citation
    Target: MET
    Summary: C-Met inhibitor,potent and selective
      ≥28.4 mg/mL
  8. EGF816
    B5889 EGF816
     2 Citation
    Target: EGFR
    Summary: Novel covalent inhibitor of mutant-selective EGFR
      Soluble in DMSO
  9. MLR 1023
    B5648 MLR 1023
    Target: Lyn kinase
    Summary: allosteric activator of Lyn kinase
  10. Brivanib (BMS-540215)
    A2597 Brivanib (BMS-540215)
    Target: VEGFR|FGFR|Flk1
    Summary: VEGFR-2 inhibitor,ATP-competitive
      insoluble in H2O; ≥18.5 mg/mL

Items 11-20 of 65

Page
per page
Shop By
Now Shopping by
  1. Category Tyrosine Kinase Remove This Item
  2. Reported Experiments Animal Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Bcr-Abl 2item
  2. Axl 1 item
  3. ALK 2item
  4. c-FMS 1 item
  5. c-Kit 1 item
  6. c-MET 7item
  7. c-RET 4item
  8. CSF-1R 1 item
  9. EGFR 12item
  10. FAK 3item
  11. FGFR 5item
  12. FLT3 1 item
  13. HER2 5item
  14. IGF1R 1 item
  15. LRRK2 4item
  16. PDGFR 6item
  17. Pyk2 2item
  18. Spleen Tyrosine Kinase (Syk) 1 item
  19. Src 4item
  20. Tie-2 2item
  21. Trk 1 item
  22. VEGFR 21item
Specificity
  1. Selective 48item
Reversibility
  1. Reversible 7item
  2. Irreversible 4item
Target
  1. Raf 5item
  2. Aurora Kinases 1 item
  3. CSF-1R 1 item
  4. FLT3 4item
  5. Eph Receptors 1 item
  6. VEGFR 27item
  7. PDGFR 8item
  8. c-Kit 6item
  9. RET 2item
  10. Bcr-Abl 1 item
  11. FGFR 7item
  12. MET 4item
  13. Src 3item
  14. Trk Receptors 2item
  15. EGFR 11item
  16. FAK 3item
  17. BMP and Other Activin Receptors 1 item
  18. JAK 1 item
  19. Syk 1 item
  20. ErbB 2item
  21. c-MET 2item
  22. HER2 1 item
  23. Pyk2 3item
  24. LRRK2 4item
  25. Insulin and Insulin-like Receptors 2item
  26. ALK 1 item
  27. Tie-2 3item
  28. ZAP-70 1 item
  29. Flk-1 1 item
  30. c-RET 1 item
  31. KDR 1 item
  32. Fyn kinase 1 item
  33. c-Fms tyrosine kinase 1 item
  34. Lyn kinase 1 item
  35. ErbB-2 1 item
  36. DCLK2 1 item
  37. Flk1 1 item
Related Disease
  1. Acute Myeloid Leukemia 2item
  2. Adrenocortical Carcinoma 1 item
  3. Advanced Renal Cell Carcinoma 1 item
  4. Autoimmune Diseases 1 item
  5. Bladder Cancer 3item
  6. Bladder Carcinoma 1 item
  7. Breast Cancer 14item
  8. Cancer 49item
  9. Cholangiocarcinoma 1 item
  10. Chronic Lymphocytic Leukemia 1 item
  11. Clear Cell Renal Cell Carcinoma 1 item
  12. Colon Cancer 3item
  13. Colon Carcinoma 1 item
  14. Colorectal Cancer 9item
  15. Glioblastoma 3item
  16. Glioma 2item
  17. Hepatocellular Carcinoma 2item
  18. Liver Cancer 2item
  19. Lung Cancer 5item
  20. Lung Carcinoma 1 item
  21. Lymphoma 1 item
  22. Melanoma 1 item
  23. Multiple Myeloma 3item
  24. Non-small Cell Lung Cancer 3item
  25. Ovarian Cancer 4item
  26. Pancreatic Cancer 7item
  27. Prostate Cancer 5item
  28. Renal Cancer 2item
  29. Renal Cell Carcinoma 3item
  30. Thyroid Cancer 3item